Michael Seiden, MD, PhD
Former President, US Oncology NetworkBio
Gregory TenBarge, MHA
Chief Administration Officer, Envision Medical GroupBio
Blue Note's products will serve all cancer patients, from early stage through survivorship, in both the in-patient and out-patient settings.
|Product Candidate||Disease Progression||Development||Proof of Concept||Pivotal Trial||FDA Review|
|BNT001||Diagnosis --> Survivorship||✕||✕||✕||✕|
|Product Candidate||Disease Progression||Status|
|BNT001||Diagnosis --> Survivorship||3|
Blue Note Therapeutics is honored to work with the National Comprehensive Cancer Network (NCCN) and other leading cancer care organizations in our quest to help cancer patients live better.